Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   The TY3 Gag3 Spacer Controls Intracellular Condensation and Uncoating
  2. Clemens, K.; Larsen, L.; Zhang, M.; Kuznetsov, Y.; Bilanchone, V.; Randall, A.; Harned, A.; DaSilva, R.; Nagashima, K.; McPherson, A.; Baldi, P.; Sandmeyer, S.
  3. Journal of Virology. 2011, Apr; 85(7): 3055-3066.
  1. 2.   Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy
  2. McKinnon, J. E.; Delgado, R.; Pulido, F.; Shao, W.; Arribas, J. R.; Mellors, J. W.
  3. Antiviral Therapy. 2011 16(5): 725-732.
  1. 3.   The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation
  2. Checkley, M. A.; Luttge, B. G.; Soheilian, F.; Nagashima, K.; Freed, E. O.
  3. Virology. 2010, Apr; 400(1): 137-144.
  1. 4.   Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1 maturation inhibitor bevirimat
  2. Adamson, C. S.; Sakalian, M.; Salzwedel, K.; Freed, E. O.
  3. Retrovirology. 2010, Apr; 7: 8.
  1. 5.   Impact of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors on Evolution of Resistance to the Maturation Inhibitor Bevirimat (PA-457)
  2. Adamson, C. S.; Waki, K.; Ablan, S. D.; Salzwedel, K.; Freed, E. O.
  3. Journal of Virology. 2009 83(10): 4884-4894.
  1. 6.   HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions
  2. Olivares, I.; Mulky, A.; Boross, P. I.; Tozser, J.; Kappes, J. C.; Lopez-Galindez, C.; Menendez-Arias, L.
  3. Journal of Molecular Biology. 2007, Sep; 372(2): 369-381.
  1. 7.   In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat)
  2. Adamson, C. S.; Ablan, S. D.; Boeras, I.; Goila-Gaur, R.; Soheilian, F.; Nagashima, K.; Li, F.; Salzwedel, K.; Sakalian, M.; Wild, C. T.; Freed, E. O.
  3. Journal of Virology. 2006, Nov; 80(22): 10957-10971.
  1. 8.   Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease
  2. Feher, A.; Boross, P.; Sperka, T.; Miklossy, G.; Kadas, J.; Bagossi, P.; Oroszlan, S.; Weber, I. T.; Tozser, J.
  3. Journal of General Virology. 2006, May; 87: 1321-1330.
  1. 9.   Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase
  2. Mitchell, M. S.; Tozser, J.; Princler, G.; Lloyd, P. A.; Auth, A.; Derse, D.
  3. Journal of Biological Chemistry. 2006, FEB 17; 281(7): 3964-3971.
  1. 10.   In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: Effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence
  2. Tozser, J.; Shulenin, S.; Louis, J. M.; Copeland, T. D.; Oroszlan, S.
  3. Biochemistry. 2004 43(14): 4304-4312.
  1. 11.   Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases
  2. Tozser, J.; Zahuczky, G.; Bagossi, P.; Louis, J. M.; Copeland, T. D.; Oroszlan, S.; Harrison, R. W.; Weber, I. T.
  3. European Journal of Biochemistry. 2000 267(20): 6287-6295.
  1. 12.   Effect of substrate residues on the P2 ' preference of retroviral proteinases
  2. Boross, P.; Bagossi, P.; Copeland, T. D.; Oroszlan, S.; Louis, J. M.; Tozser, J.
  3. European Journal of Biochemistry. 1999 264(3): 921-929.
  1. 13.   Comparison of the Specificity of Homo- and Heterodimeric Linked Hiv-1 and Hiv-2 Proteinase Dimers
  2. Bagossi, P.; Cheng, Y. S. E.; Oroszlan, S.; Tozser, J.
  3. Protein Engineering. 1998 11(6): 439-445.
  1. 14.   Studies On the Symmetry and Sequence Context Dependence of the Hiv-1 Proteinase Specificity
  2. Tozser, J.; Bagossi, P.; Weber, I. T.; Louis, J. M.; Copeland, T. D.; Oroszlan, S.
  3. Journal of Biological Chemistry. 1997 272(27): 16807-16814.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel